| Patents for A61P 37 - Drugs for immunological or allergic disorders (117,141) |
|---|
| 04/06/2006 | US20060074092 Cysteine protease inhibitors with 2-cyano-4-amino-pyrimidine structure and cathepsin K inhibitory activity for the treatment of inflammations and other diseases |
| 04/06/2006 | US20060074074 Reacting compounds such as 5-(3,4-dimethoxybenzoyl)-2-(1-isopropoxycarbonyloxy-2-methylpropyl)-2-1,2,3-triazole-4-carboxylate with carbonyl compounds, reacting with an alcohol to produce 1-(1-Isopropoxycarbonyloxyethyl)-7,8-dimethoxy-4(5H),10-dioxo-1H-1,2,3-triazolo[4,5-c][1]benzazepine |
| 04/06/2006 | US20060074037 Producing/evaluating a protein/polypeptide (alpha-defensin) with increased antimicrobial activity and stability to effect chemotaxis of T-cells, neutrophil recruitment, or cytokine or interleukin-8 release; immunostimulants; respiratory system disorders; inflammatory bowel disease; viricides; cancer; HIV |
| 04/06/2006 | US20060073567 Novel insulin/IGF/relaxin family polypeptides and DNAs thereof |
| 04/06/2006 | US20060073223 Phloridzin-rich phenolic fraction and use thereof as a cosmetic, dietary or nutraceutical agent |
| 04/06/2006 | US20060073162 Preparation and standardization of immunomodulatory peptide-linked glucans with verifiable oral absorbability from coriolus versicolor |
| 04/06/2006 | US20060073146 Uses of agonists and antagonists to modulate activity of TNF-related molecules |
| 04/06/2006 | US20060073137 Humanised antibodies |
| 04/06/2006 | US20060073136 Humanised antibodies |
| 04/06/2006 | US20060073114 Compounds and methods to inhibit or augment an inflammatory response |
| 04/06/2006 | DE10231370B4 Thiophenglycosidderivate, diese Verbindungen enthaltende Arzneimittel und Verfahren zur Herstellung dieser Arzneimittel Thiophenglycosidderivate, pharmaceutical compositions containing them and methods for making these drugs |
| 04/06/2006 | DE102004047262A1 Pharmazeutisches Mittel umfassend Blutprodukte und deren Verwendung als Injektions- oder Infusionsmittel zur Prophylaxe und Behandlung von Defekten des Immunsystems beim Menschen A pharmaceutical composition comprising blood products and their use as injection or infusion agent for the prophylaxis and treatment of defects of the immune system in humans |
| 04/06/2006 | DE102004046990A1 Pharmazeutischer Wirkstoff zur Stärkung des Immunsystems Active pharmaceutical ingredient for boosting the immune system |
| 04/06/2006 | CA2582071A1 Unsubstituted and substituted 4-benzyl-1,3-dihydro-imidazole-2-thiones acting as specific or selective alpha2 adrenergic agonists and methods for using the same |
| 04/06/2006 | CA2581828A1 4-(heteroaryl-methyl and substituted heteroaryl-methyl)-imidazole-2-thiones acting as alpha2 adrenergic agonists |
| 04/06/2006 | CA2581741A1 Histamine-3 receptor antagonists |
| 04/06/2006 | CA2581579A1 4-(phenylmethyl and substituted phenylmethyl)-imidazole-2-thiones acting as specific alpha2 adrenergic agonists |
| 04/06/2006 | CA2580798A1 Methods for the generation of hepatocyte-like cells from human blastocyst-derived stem (hbs) |
| 04/05/2006 | EP1642979A1 Fucosyltransferase gene |
| 04/05/2006 | EP1642974A1 Recombinant soluble Fc receptors |
| 04/05/2006 | EP1642973A1 Therapeutic uses of BR43X2 soluble receptors |
| 04/05/2006 | EP1642972A1 Therapeutic uses of BR43X2 soluble receptors |
| 04/05/2006 | EP1642903A1 Peptide having apoptosis-inhibiting activity |
| 04/05/2006 | EP1642900A1 Tricyclic triazolobenzazepine derivative produced as novel crystalline substance |
| 04/05/2006 | EP1642596A2 Treatment of autoimmune diseases with antagonists which bind to B cell surface markers |
| 04/05/2006 | EP1642591A1 MEDICINAL COMPOSITION CONTAINING NF-kAPPA B DECOY FOR TREATING AND PREVENTING RESPIRATORY DISEASES AND METHOD OF USING THE SAME |
| 04/05/2006 | EP1642574A2 Combination of a beta-2 adrenoceptor agonist and an aminosugar and their use for the treatment of immunomodulatory disorders |
| 04/05/2006 | EP1641926A2 Therapeutic use of lpi, a staphylococcal lectin pathway inhibitor in inflammatory diseases |
| 04/05/2006 | EP1641789A2 Benzothiazole-4,7-diones and benzoxazole-4,7-diones with substituents in position 5 or 6 and method for production thereof |
| 04/05/2006 | EP1641779A1 2-substitued 5, 6-diaryl-pyrazine derivatives as cb1 modulator. |
| 04/05/2006 | EP1641771A1 Hydroxamate sulfonamides as cd23 shedding inhibitors |
| 04/05/2006 | EP1641763A2 4-cyanopyrazole-3-carboxamide derivatives preparation and therapeutic application thereof |
| 04/05/2006 | EP1641758A2 Diphenylpyridine derivatives, preparation and therapeutic application thereof |
| 04/05/2006 | EP1641474A1 Therapeutical composition containing dentritic cells and use thereof |
| 04/05/2006 | EP1641467A1 (20s)-1alpha-hydroxy-2-methylene-19-nor-vitamin d3 and its uses |
| 04/05/2006 | EP1453777B1 Functionalized higher diamondoids |
| 04/05/2006 | EP1450822A4 Polymeric thiol-linked prodrugs |
| 04/05/2006 | EP1438104B1 Co-cycloalkyl 17-heteroaryl prostaglandin e2 analogs as ep2-receptor agonists |
| 04/05/2006 | EP1353689B1 Immunizing compositions and methods of use |
| 04/05/2006 | EP1351969A4 Method for generating immortal dendritic cell lines |
| 04/05/2006 | EP1280524B1 Methods and compositions for modulating alpha adrenergic receptor activity |
| 04/05/2006 | EP1244668B1 Purine derivatives, process for their preparation and use thereof |
| 04/05/2006 | EP1210104B1 Nanoparticulate compositions comprising amorphous cyclosporine and methods of making and using such compositions |
| 04/05/2006 | EP1107783B1 Method for inducing a cell-mediated immune response and parenteral vaccine formulations therefor |
| 04/05/2006 | EP1094824B1 Prophylactic and therapeutic nutritional supplement for creation/maintenance of health-protective intestinal microflora and enhancement of the immune system |
| 04/05/2006 | EP1085901B1 Transdermal use of secretin for the treatment of autism |
| 04/05/2006 | EP0991660B8 DEUTERATED and undeuterated CYCLOSPORINE ANALOGS AND THEIR USE AS IMMUNOMODULATING AGENTS |
| 04/05/2006 | CN1756768A Trimeric polypeptide construct to induce an enduring t cell response |
| 04/05/2006 | CN1756763A Dimerized peptide |
| 04/05/2006 | CN1756753A Benzofuran derivative |
| 04/05/2006 | CN1756561A Immunotherapy of B cell malignancies and autoimmune diseases using unconjugated antibodies and conjugated antibodies and antibody combinations and fusion proteins |
| 04/05/2006 | CN1756548A Pharmaceutical compositions comprising a combination of rapamycin or its derivative and pimecrolimus for the treatment of inflammation- and ummunologically-mediated diseases |
| 04/05/2006 | CN1756546A Microglia inhibitors for interrupting interleukin 12 and ifn-gamma-mediated immune reactions |
| 04/05/2006 | CN1754892A Preparation method and application of Asiatic polysaccharide |
| 04/05/2006 | CN1754565A Green dendrobium stem compostition and its preparation method |
| 04/05/2006 | CN1754564A Green dendrobium stem pharmaceutical compostition and its preparation method |
| 04/05/2006 | CN1754557A Chinese caterpillar fungus formulation preparation method |
| 04/05/2006 | CN1754549A Chinese caterpillar fungus formulation preparation method |
| 04/05/2006 | CN1754548A Chinese caterpillar fungus injection preparation method |
| 04/05/2006 | CN1249242C non-resistance choosing for DNA vaccine carrier and its construction method |
| 04/05/2006 | CN1249087C Novel human G-Protein coupled receptor |
| 04/05/2006 | CN1249085C Immunogenic but non-amyloidogenic synthetic peptides homologous to beta amyloid for induction of immune response to beta amyloid and amyloid deposits |
| 04/05/2006 | CN1249074C 2-aminocarbonyl-9H-punine derivatives |
| 04/05/2006 | CN1249063C Immunoregulatory compounds |
| 04/05/2006 | CN1249061C Sulfonamide and sulfamide substituted imidazoquinolines and its pharmaceutical composition and uses |
| 04/05/2006 | CN1249059C Novel piperidinecarboxamide derivatives, method for preparing same and pharmaceutical compositions containing same |
| 04/05/2006 | CN1249056C Inhibitors of dipeptidyl peptidase IV |
| 04/05/2006 | CN1249033C Cyclic amp-specific phosphodiesterase inhibitors |
| 04/05/2006 | CN1249025C Aminobenzophenones as inhibiotors of IL-1 beta and TNF-alpha |
| 04/05/2006 | CN1248737C Vaccine containing saponin and sterol |
| 04/05/2006 | CN1248736C 疫苗组合物 Vaccine compositions |
| 04/05/2006 | CN1248671C Use of 3-position cyclosporin derivatives for hair growth |
| 04/04/2006 | US7022860 2-(1-isopropoxycarbonyloxy-2-methylpropyl)-7,8-dimethoxy-4(5H),10 -dioxo-2H-1,2,3-triazolo(4,5-c)(1)benzazepine, for example; chemical intermediates, synthesis using relatively inexpensive reagents |
| 04/04/2006 | US7022856 Carboline derivatives |
| 04/04/2006 | US7022849 Quinazoline and pyrido[2,3-d]pyrimidine inhibitors of phosphodiesterase (PDE) 7 |
| 04/04/2006 | US7022738 (3S)-N-butyl-3-((2S)-2-(((4-fluorophenyl)sulfonyl)amino)-3-methylbutanoylamino)-5-methyl-2-oxohexanamide; calpain inhibition; Alzheimer's, osteoporosis, brain and eye disorders, ischemia |
| 04/04/2006 | US7022730 Protein tyrosine phosphatases inhibitors |
| 04/04/2006 | US7022729 For treating central nervous system disorders, immunomodulatory disorders, antimalaria, viral disease of Borna virus, Hepatitis; a 6-azatricyclo(6.3.1.01,6)dodecane derivatives |
| 04/04/2006 | US7022715 4-(phenyl-piperidin-4-ylidene-methyl)-benzamide derivatives and their use for the treatment of pain, anxiety or gastrointestinal disorders |
| 04/04/2006 | US7022689 5-amidino-n-(2-aminophenethyl)-n-hydroxy-benzenesulffonamide derivative, medical composition containing the same, pharmaceutical use thereof and intermediate therefor |
| 04/04/2006 | US7022687 for treatment of allergies and airway disorders such as allergic rhinitis |
| 04/04/2006 | US7022500 Humanized immunoglobulins |
| 04/04/2006 | US7022485 immunogens or target antigens comprising citrullinated polypeptide derived from fragments of fibrinogen; prophylaxis of inflammatory disorders |
| 04/04/2006 | US7022482 Deactivation antigen protein; anticancer agents; Aids therapy |
| 04/04/2006 | US7022312 Condensation aerosol as doage forms, is produced by heating a thin layer containing of dolasetron, granisetron or metoclopramide to form vapor, condense into an aerosol; fast producing peak plasma concentrations |
| 04/04/2006 | CA2356544C Pyridotriazines and pyridopyridazines |
| 04/04/2006 | CA2166315C Process for the preparation of thalidomide |
| 04/04/2006 | CA2120503C The regulation of systemic immune responses utilizing cytokines and antigens |
| 04/04/2006 | CA2116138C Methods and compositions for attenuating antibody-mediated xenograft rejection in human recipients |
| 03/30/2006 | WO2006034116A1 Diaminotriazole compounds useful as protein kinase inhibitors |
| 03/30/2006 | WO2006033453A1 Activity enhancer for interferon agent |
| 03/30/2006 | WO2006033386A1 STABILIZED HUMAN IgG4 ANTIBODIES |
| 03/30/2006 | WO2006032674A1 Virus-like particles comprising a fusion protein of the coat protein of ap205 and an antigenic polypeptide |
| 03/30/2006 | WO2006032268A1 Treatment of defects of cellular immunity with leukocyte homogenates having a molecular weight of less than 10,000 dalton |
| 03/30/2006 | WO2006010544A3 1, 1a, 5, 5a-tetrahydro-3-thia-cyclopropa’a! pentalenes: tricyclic thiophene derivatives as s1p1/edg1 receptor agonists |
| 03/30/2006 | WO2005118643A3 Antibodies to angiogenesis inhibiting domains of cd148 |
| 03/30/2006 | WO2005095460A3 Bi-specific antibodies for targeting cells involved in allergic-type reactions, compositions and uses thereof |
| 03/30/2006 | WO2005048935A3 Methods of modulating immunity |
| 03/30/2006 | WO2003014294A3 Tacis and br3 polypeptides and uses thereof |
| 03/30/2006 | US20060069246 Tumor necrosis factor receptor related proteins Tango-63d and Tango-63e |